REGULATION OF CYTOTOXIC T LYMPHOCYTE-MEDIATED GRAFT REJECTION FOLLOWING BONE MARROW
Authors:
- Stephen G. EmersonSEStephen G. Emerson
- Joseph AntinJAJoseph Antin
- Richard MaziarzRMRichard Maziarz
- Joel M. RappeportJRJoel M. Rappeport
- Brian R. SmithBSBrian R. Smith
- Steven J. BurakoffSBSteven J. Burakoff
- 1 December 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 46 (6) , 835-839
Abstract
Cytotoxic T lymphocytes have been implicated as the effector cell mediating graft rejection following human allogeneic bone marrow transplantation. We have studied a BMT patient who rejected haploidentical T cell-depleted marrow. In vitro studies demonstrated that the circulating lymphocytes were CD3+ and CD8+, of recipient origin, and exhibited selective cytotoxicity against donor-specific class I major histocompatibility complex antigens. Cytotoxicity was inhibited by monoclonal antibodies directed against CD3, CD8, CD2, and lymphocyte function-associated antigen-1 on the T cell, and against MHC class I proteins on the target cell. Furthermore, these circulating cells inhibited the in vitro growth and differentiation of enriched donor bone marrow progenitor cells, an inhibition that was partially reversed by anti-CD3 MAb. Donor-specific recipient-derived CTL may mediate resistance to engraftment, and CTL activity may be inhibited by a number of MAb. The implications of these findings for host preparation and treatment are discussed.Keywords
This publication has 21 references indexed in Scilit:
- Bone marrow graft rejection as a function of antibody-directed natural killer cells.Journal of Experimental Medicine, 1985
- The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions.The Journal of Immunology, 1983
- T CELL DEPLETION OF HUMAN BONE MARROW USING MONOCLONAL ANTIBODY AND COMPLEMENT-MEDIATED LYSISTransplantation, 1983
- Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.Proceedings of the National Academy of Sciences, 1982
- Recognition of HLA-B27 and related antigen by a monoclonal antibodyHuman Immunology, 1982
- TRANSPLANTATION FOR ACUTE LEUKAEMIA WITH HLA-A AND B NONIDENTICAL PARENTAL MARROW CELLS FRACTIONATED WITH SOYBEAN AGGLUTININ AND SHEEP RED BLOOD CELLSThe Lancet, 1981
- BONE MARROW TRANSPLANTATION ACROSS MAJOR HISTOCOMPATIBILITY BARRIERS IN MICE EFFECT OF ELIMINATION OF T CELLS FROM DONOR GRAFTS BY TREATMENT WITH MONOCLONAL THY-1.2 PLUS COMPLEMENT OR ANTIBODY ALONETransplantation, 1981
- Use of a Monoclonal Antibody (W6/32) in Structural Studies of HLA-A,B,C AntigensThe Journal of Immunology, 1979
- Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.Journal of Experimental Medicine, 1978
- Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic graftsEuropean Journal of Immunology, 1977